Prions and their partners in crime
The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
Prions, the infectious agents of transmissible spongiform encephalopathies (TSEs), have defied full characterization for decades. The dogma has been that prions lack nucleic acids and are composed of a pathological, self-inducing form of the host's prion protein (PrP). Recent progress in propagating TSE infectivity in cell-free systems has effectively ruled out the involvement of foreign nucleic acids. However, host-derived nucleic acids or other non-PrP molecules seem to be crucial. Interactions between TSE-associated PrP and its normal counterpart are also pathologically important, so the physiological functions of normal PrP and how they might be corrupted by TSE infections have been the subject of recent research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PrPSc levels are in many cases poorly correlated with prion disease progression, suggesting that it is necessary but not sufficient; ‘something else’ is required”
Citations
Cites
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Self-citationThe cellular prion protein binds copper in vivo
Brown, D. R., Qin, K., Herms, J. W., Madlung, A., Manson, J., Strome, R., Fraser, P. E., Kruck, T., von Bohlen, A., Schulz-Schaeffer, W., et al. (1997) · Nature · doi:10.1038/37783 · Cited by 1,273
Legname, G., Baskakov, I. V., Nguyen, H.-O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2004) · Science · doi:10.1126/science.1100195 · Cited by 1,021 · cited 1×
“One team showed that synthetic truncated PrP fibril preparations can induce TSE disease when inoculated into transgenic mice that vastly overexpress the same truncated PrP construc”
BackgroundCells release prions in association with exosomes
Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., Laude, H., & Raposo, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308413101 · Cited by 997
S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration
Uehara, T., Nakamura, T., Yao, D., Shi, Z.-Q., Gu, Z., Ma, Y., Masliah, E., Nomura, Y., & Lipton, S. A. (2006) · Nature · doi:10.1038/nature04782 · Cited by 906
The most infectious prion protein particles
Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F., & Caughey, B. (2005) · Nature · doi:10.1038/nature03989 · Cited by 899 · cited 2×
“To better characterize the minimal infectious unit and the most infectious particles per unit protein, Silveira et al.(17) developed new methods for gently disaggregating scrapie prion aggregates in detergent and separating them by size using flow field-flow fractionation.”
MethodSelf-citationNormal host prion protein necessary for scrapie-induced neurotoxicity
Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., & Aguzzi, A. (1996) · Nature · doi:10.1038/379339a0 · Cited by 810 · cited 1×
“This is consistent with earlier studies that described reduced PrPres-induced neuropathology in brain tissue that lacks PrP C (ref”
ResultPrion protein is necessary for normal synaptic function
Collinge, J., Whittington, M. A., Sidle, K. C. L., Smith, C. J., Palmer, M. S., Clarke, A. R., & Jefferys, J. G. R. (1994) · Nature · doi:10.1038/370295a0 · Cited by 799
In Vitro Generation of Infectious Scrapie Prions
Castilla, J., Saá, P., Hetz, C., & Soto, C. (2005) · Cell · doi:10.1016/j.cell.2005.02.011 · Cited by 790 · cited 1×
“have demonstrated the cell-free propagation of PrPres and accompanying robust TSE infectivity, but many molecules besides PrP were also presen”
BackgroundDepleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P.-C., Brandner, S., & Collinge, J. (2003) · Science · doi:10.1126/science.1090187 · Cited by 770
Research works printed but not linked: 1
- Ben-Zaken, O. et al. Cellular heparan sulfate participates in the metabolism of prions. J. Biol. Chem. 278, 40041–40049 (2003). · DOI · Paper page
Cited by
Items 101–200 of 294
Hierarchical self-assembly of a β-amyloid peptide derivative
Qin, S., Pei, Y., Liu, X., Zhuo, R., & Zhang, X. (2012) · Journal of Materials Chemistry B · doi:10.1039/c2tb00105e · Cited by 41
Antiprion activity of functionalized 9-aminoacridines related to quinacrine
Thi, H. T. N., Lee, C. Y., Teruya, K., Ong, W.-Y., Doh‐ura, K., & Go, M. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.060 · Cited by 42
Nucleic acid-mediated protein aggregation and assembly
Liu, C., & Zhang, Y. (2011) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-386483-3.00005-7 · Cited by 42
Application of DNA methyltransferases in targeted DNA methylation
Jeltsch, A., Jurkowska, R. Z., Jurkowski, T. P., Liebert, K., Rathert, P., & Schlickenrieder, M. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-0966-0 · Cited by 42
“Examples include diseases accompanied by accumulation and aggregation of endogenous proteins, like the amyloid precursor protein (APP) and tau proteins in Alzheimer’s disease (review, Weiner and Frenkel 2006), mutated Huntingtin in Chorea Huntington (review, Borrell-Pages et al. 2006), α-synuclein in Parkinson’s disea…”
BackgroundStefureac, R. I., Madampage, C. A., Andrievskaia, O., & Lee, J. S. (2010) · Biochemistry and Cell Biology · doi:10.1139/o09-176 · Cited by 40
“Finally, PrPC has been shown to interact with a large number of ligands including at least 15 other proteins (Caughey and Baron 2006; Marc et al. 2007), DNA (Lima et al.”
BackgroundThe shared and specific mechanism of four autoimmune diseases
Luan, M., Shang, Z., Teng, Y., Chen, X., Zhang, M., Lv, H., & Zhang, R. (2017) · Oncotarget · doi:10.18632/oncotarget.19383 · Cited by 41
“In addition, the conformational transition could lead to loss of a beneficial activity that protein PrPC is the natively folded [31].”
BackgroundInfluentialCyclic Tetrapyrrole Sulfonation, Metals, and Oligomerization in Antiprion Activity
Caughey, W. S., Priola, S. A., Kocisko, D. A., Raymond, L. D., Ward, A. E., & Caughey, B. W. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01599-06 · Cited by 37
“TSE pathogenesis involves the conversion of the normally protease-sensitive prion protein (PrP-sen or PrP) to a protease-resistant amyloidogenic oligomer/multimer called PrP-res or PrP (reviewed in (2)).”
BackgroundSelf-citationThellung, S., Villa, V., Corsaro, A., Pellistri, F., Venezia, V., Russo, C., Aceto, A., Robello, M., & Florio, T. (2007) · Glia · doi:10.1002/glia.20559 · Cited by 40
FBXW7-Induced MTOR Degradation Forces Autophagy to Counteract Persistent Prion Infection
Xu, Y., Tian, C., Sun, J. F., Zhang, J., Ren, K., Fan, X., Wang, K., Wang, H., Yan, Y., Chen, C., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9028-7 · Cited by 37
Cytoplasmic prion protein induces forebrain neurotoxicity
Wang, X., Bowers, S., Wang, F., Pu, X.-A., Nelson, R. J., & Ma, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.014 · Cited by 41
“INTRODUCTION Prion diseases are a group of neurodegenerative disorders characterized by the conversion of normal prion protein (PrP) to a pathogenic conformation (PrP) [1-4].”
BackgroundStructural biology of ex vivo mammalian prions
Artikis, E., Kraus, A., & Caughey, B. W. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102181 · Cited by 37
Self-citationPaquet, S., Daude, N., Courageot, M.-P., Chapuis, J., Laude, H., & Vilette, D. (2007) · Journal of Virology · doi:10.1128/jvi.01137-07 · Cited by 47
“Among the potential cellular receptors that could interact with and promote the entry of PrP, a prime candidate is the cellular form of PrP (6), which is constitutively endocytosed from the cell surface to intracellular compartments (15, 28).”
BackgroundThe prion protein binds thiamine
Pérez, R., Bjorndahl, T. C., Berjanskii, M. V., Hau, D., Li, L., Huang, A., Lee, R. A., Gibbs, E., Ladner-Keay, C. L., Dong, Y., et al. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08304.x · Cited by 33
Docking Ligands on Protein Surfaces: The Case Study of Prion Protein
Kranjc, A., Bongarzone, S., Rossetti, G., Biarnés, X., Cavalli, A., Bolognesi, M. L., Roberti, M., Legname, G., & Carloni, P. (2009) · Journal of Chemical Theory and Computation · doi:10.1021/ct900257t · Cited by 33
PrP interactions with nucleic acids and glycosaminoglycans in function and disease
Jerson, L. S. (2009) · Frontiers in bioscience · doi:10.2741/3611 · Cited by 34
“Several groups have suggested that an additional, unknown factor may initiate or modulate the conversion of PrP to PrP (38, 48-52).”
BackgroundSteele, A. D., King, O., Jackson, W., Hetz, C., Borkowski, A., Thielen, P., Wollmann, R. L., & Lindquist, S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3290-07.2007 · Cited by 33
“Prion diseases (PrD) are a unique class of neurodegenerative disorders manifesting in genetic, sporadic, and infectious forms, affecting humans as well as wild and domesticated animals (Prusiner, 1998; Aguzzi and Heikenwalder, 2006; Caughey and Baron, 2006).”
BackgroundSantos, T. G., Beraldo, F. H., Hajj, G. N. M., Lopes, M. H., Roffé, M., Lupinacci, F. C. S., Ostapchenko, V. G., Prado, V. F., Prado, M. A. M., & Martins, V. R. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12091 · Cited by 37
Bongarzone, S., Tran, H. N. A., Cavalli, A., Roberti, M., Carloni, P., Legname, G., & Bolognesi, M. L. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100882t · Cited by 32
Prion potency in stem cells biology
Lopes, M. H., & Santos, T. G. (2012) · Prion · doi:10.4161/pri.19035 · Cited by 33
Differential stability of the bovine prion protein upon urea unfolding
Julien, O., Chatterjee, S., Thiessen, A., Graether, S. P., & Sykes, B. D. (2009) · Protein Science · doi:10.1002/pro.231 · Cited by 34
Induced Prion Protein Controls Immune-Activated Retroviruses in the Mouse Spleen
Lötscher, M., Recher, M., Lang, K. S., Navarini, A. A., Hunziker, L., Santimaria, R., Glatzel, M., Schwarz, P., Böni, J., & Zinkernagel, R. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001158 · Cited by 32
“Yet, this dogma awaits to be proven and is challenged by strong evidence for the involvement of non-PrP molecules as ‘‘partners in crime’’ [4].”
Asuni, A. A., Gray, B., Bailey, J., Skipp, P., Perry, V. H., & O'Connor, V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.502690 · Cited by 31
“Prion disease progression is characterized by activated microglia, astrogliosis, vacuolation, spongiform degeneration, and neuronal loss (5), and many of these neuropathological features are observed in AD (6).”
BackgroundMolecular foundations of prion strain diversity
Carta, M. C., & Aguzzi, A. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.07.010 · Cited by 33
Prion Protein Biology Through the Lens of Liquid-Liquid Phase Separation
Agarwal, A., & Mukhopadhyay, S. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167368 · Cited by 34
Rapid Transepithelial Transport of Prions following Inhalation
Kincaid, A. E., Hudson, K. F., Richey, M. W., & Bartz, J. C. (2012) · Journal of Virology · doi:10.1128/jvi.01930-12 · Cited by 30
“diate filament of astrocytes and therefore is a component of both infected and uninfected brain homogenates, while PrP is found only in prion-infected brain homogenate (8, 14, 21).”
BackgroundAptamers against prion proteins and prions
Gilch, S., & Schätzl, H. M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0031-5 · Cited by 36
Alvarez‐Martinez, M., Fontès, P., Zomosa‐Signoret, V., Arnaud, J.-D., Hingant, E., Pujo-Menjouet, L., & Liautard, J. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.05.016 · Cited by 33
“In the particular case of the prion proteins, amyloids or amyloid-like assemblies become self-perpetuating in vivo and thus turn into pathological infectious agents in mammals or protein-based genetic elements in yeast [7].”
BackgroundGlypican‐1 facilitates prion conversion in lipid rafts
Hooper, N. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06936.x · Cited by 31
Deriziotis, P., & Tabrizi, S. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.06.011 · Cited by 38
“beyond the scope of this review but has been recently reviewed [64–66].”
BackgroundLeft handed β helix models for mammalian prion fibrils
Kunes, K. C., Clark, S., Cox, D. L., & Singh, R. R. (2008) · Prion · doi:10.4161/pri.2.2.7059 · Cited by 31
“, include these residues in the helical thread; (3) Langedijk et al.”
BackgroundMethodInfluentialEnergy barriers for HET‐s prion forming domain amyloid formation
Sabaté, R., Castillo, V., Espargaró, A., Saupe, S. J., & Ventura, S. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07202.x · Cited by 27
Choi, Y. P., Peden, A., Gröner, A., Ironside, J. W., & Head, M. W. (2010) · Journal of Virology · doi:10.1128/jvi.01057-10 · Cited by 28
Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS
Asante, E. A., Grimshaw, A., Smidak, M., Jakubcova, T., Tomlinson, A., Jeelani, A., Hamdan, S., Powell, C., Joiner, S., Linehan, J. M., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004953 · Cited by 27
“It is proposed that PrP is the infectious agent acting to replicate itself with high fidelity by recruiting endogenous PrP and that the difference between these isoforms lies purely in the monomer conformation and its state of aggregation [1,2,8] although it is now clear that infectivity can also be associated with pr…”
BackgroundGlycosaminoglycan Sulphation Affects the Seeded Misfolding of a Mutant Prion Protein
Lawson, V., Lumicisi, B., Welton, J. M., Machalek, D. A., Gouramanis, K., Klemm, H. M. J., Stewart, J., Masters, C. L., Hoke, D. E., Collins, S. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012351 · Cited by 26
“Previously, the efficiency of this process using partially purified constituents has been low, often requiring a large excess of PrP, which has been proposed to reflect the need for a catalytic co-factor in the process [8,9].”
BackgroundGPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells
Speare, J. O., Offerdahl, D. K., Hasenkrug, A. M., Carmody, A., & Baron, G. S. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.392 · Cited by 29
“…include membrane painting (Medof et al, 1996) and/or transport on intercellular processes such as exosomes, microparticles, filopodia, and tunnelling nanotubes (Fevrier et al, 2004; Caughey and Baron, 2006; Sherer et al, 2007; Sowinski et al, 2008; Caughey et al, 2009; Gousset et al, 2009).”
BackgroundSelf-citationYin, S., Fan, X., Yu, S., Li, C., & Sy, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800814200 · Cited by 26
Julien, O., Chatterjee, S., Bjorndahl, T. C., Sweeting, B., Acharya, S., Semenchenko, V., Chakrabartty, A., PAI, E. F., Wishart, D. S., Sykes, B. D., et al. (2011) · Biochemistry · doi:10.1021/bi200731e · Cited by 26
Understanding the natural variability of prion diseases
Geissen, M., Krasemann, S., Matschke, J., & Glatzel, M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.041 · Cited by 24
Nanomechanical Properties of Human Prion Protein Amyloid as Probed by Force Spectroscopy
Ganchev, D. N., Cobb, N. J., Surewicz, K. A., & Surewicz, W. K. (2008) · Biophysical Journal · doi:10.1529/biophysj.108.133108 · Cited by 23
Shedding light on prion disease
Glatzel, M., Linsenmeier, L., Dohler, F., Krasemann, S., Puig, B., & Altmeppen, H. C. (2015) · Prion · doi:10.1080/19336896.2015.1065371 · Cited by 23
The ins and outs of phosphatidylethanolamine synthesis in Trypanosoma brucei
Farine, L., & Bütikofer, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.09.008 · Cited by 21
Nucleic acid induced protein aggregation and its role in biology and pathology
Yin, J., Chen, R., & Liu, C. (2009) · Frontiers in bioscience · doi:10.2741/3588 · Cited by 22
Biosynthesis of Prion Protein Nucleocytoplasmic Isoforms by Alternative Initiation of Translation
Juanes, M. E., Elvira, G., García‐Grande, A., Calero, M., & Gasset, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804051200 · Cited by 21
RetractedTemperature Dependence of the Aggregation Kinetics of Sup35 and Ure2p Yeast Prions
Sabaté, R., Villar‐Piqué, A., Espargaró, A., & Ventura, S. (2011) · Biomacromolecules · doi:10.1021/bm201527m · Cited by 20
Paradoxical Role of Prion Protein Aggregates in Redox-Iron Induced Toxicity
Das, D., Luo, X., Singh, A., Gu, Y., Ghosh, S. K., Mukhopadhyay, C. K., Chen, S. G., Sy, M., Kong, Q., & Singh, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011420 · Cited by 21
“Sporadic Creutzfeldt-Jakob disease (sCJD) is a typical example [2–4].”
BackgroundPrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection
Marshall, K. E., Hughson, A. G., Vascellari, S., Priola, S. A., Sakudo, A., Onodera, T., & Baron, G. S. (2016) · Journal of Virology · doi:10.1128/jvi.01686-16 · Cited by 22
Self-citationContinues administration of Nano-PSO significantly increased survival of genetic CJD mice
Binyamin, O., Keller, G., Frid, K., Larush, L., Magdassi, S., & Gabizon, R. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.012 · Cited by 22
“…while it is well established that the initial conversion of PrP C into PrP Sc signals the initiation of the neurodegenerative process in prion diseases(Prusiner, 2013), other unknown factors may come into play thereafter (Caughey and Baron, 2006) which determine the rate of disease aggravation.”
Meneghetti, E., Gasperini, L., Virgilio, T., Moda, F., Tagliavini, F., Benetti, F., & Legname, G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1505-6 · Cited by 21
To develop with or without the prion protein
Halliez, S., Passet, B., Martin‐Lannerée, S., Hernandez-Rapp, J., Laude, H., Mouillet‐Richard, S., Vilotte, J.-L., & Béringue, V. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00058 · Cited by 24
“, Lopes, M. H., Roffe, M., Lupinacci, F. C., et al. (2013). Laminin-gamma1 chain and stress inducible protein 1 synergistically mediate PrPC-dependent axonal growth via Ca2+ mobilization in dorsal root ganglia neurons.”
BackgroundInfluentialExpression of cellular prion protein (PrPc) in schizophrenia, bipolar disorder, and depression
Weis, S., Haybaeck, J., Dulay, J. R., & Llenos, I. C. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0013-4 · Cited by 23
“interaction plays a role in the learning/memory pathway, (e) mediator of neuronal survival and differentiation, (f) modulator of apoptosis, as well as (g) in signal transduction (cAMP, PKA, ERK; for review see Brown 2001, 2004; Mastrangelo and Westaway 2001; Martins et al. 2002; Prado et al. 2003; Martins and Brentani…”
BackgroundCell-cell nanotubes: Tunneling through several types of synapses
Tarakanov, A. O., & Goncharova, L. B. (2009) · Communicative & Integrative Biology · doi:10.4161/cib.2.4.8289 · Cited by 21
Prion Proteins Leading to Neurodegeneration
Mendola, D. L., Pietropaolo, A., Pappalardo, G., Zannoni, C., & Rizzarelli, E. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898415 · Cited by 25
Greenwood, A. D., Vincendeau, M., Schmädicke, A.-C., Montag, J., Seifarth, W., & Motzkus, D. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-44 · Cited by 21
“As a result, several researchers have hypothesized that host-derived nucleic acids or other non-PrP molecules contribute to the propagation of prions [7-10].”
BackgroundLeliveld, S. R., Stitz, L., & Korth, C. (2008) · Biochemistry · doi:10.1021/bi800253c · Cited by 20
Tran, H. N. A., Bongarzone, S., Carloni, P., Legname, G., & Bolognesi, M. L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.149 · Cited by 19
Genetics of Prion Disease in Cattle
Murdoch, B. M., & Murdoch, G. K. (2015) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s29678 · Cited by 22
Albert, A., Yunta, C., Arranz, R., Peña, Á., SALIDO, E. C., Valpuesta, J., & Martín‐Benito, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.062471 · Cited by 18
Polyakova, O., Dear, D. V., Štern, I., Martin, S. R., Hirst, E. M. A., Bawumia, S., Nash, A., Dodson, G. G., Bronstein, I. B., & Bayley, P. M. (2008) · European Biophysics Journal · doi:10.1007/s00249-008-0371-3 · Cited by 22
“by FTIR (Pan et al. 1993), and typiWed in many diseased states by characteristic deposits, such as the toxic scrapie form, PrP Sc , is still unknown ( Caughey and Baron 2006 ).”
BackgroundThe pathological prion protein forms ionic conductance in lipid bilayer
Paulis, D., Maras, B., Schininà, M. E., Francesco, L. D., Principe, S., Galeno, R., Abdel–Haq, H., Cardone, F., Florio, T., Pocchiari, M., et al. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.04.008 · Cited by 18
“Though, we cannot exclude that these and other minor components that copurify with PrP27–30 may constitute an aid in the proper interaction of PrP27–30 with lipids for the pore formation (Giorgi et al., 2009; Kellings et al., 1992; Caughey and Baron, 2006).”
BackgroundInteraction between dendritic cells and nerve fibres in lymphoid organs after oral scrapie exposure
Dorban, G., Defaweux, V., Demonceau, C., Flandroy, S., Lerberghe, P. V., Falisse-Poirrier, N., Piret, J., Heinen, E., & Antoine, N. (2007) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-007-0476-6 · Cited by 18
“Others have proposed that prions are transported directly via small intercellular projections known as tunnelling nanotubes [9].”
BackgroundThe Fatal Attraction Between Pro-Prion and Filamin A: Prion As a Marker in Human Cancers
Sy, M., Li, C., Yu, S., & Xin, W. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.14 · Cited by 19
The application of in vitro cell-free conversion systems to human prion diseases
Jones, M., Peden, A., Head, M. W., & Ironside, J. W. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0708-8 · Cited by 18
“critical process are still the subject of speculation [22, 95].”
BackgroundTwo Misfolding Routes for the Prion Protein around pH 4.5
Garrec, J., Tavernelli, I., & Röthlisberger, U. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003057 · Cited by 20
“Such conformational shift could be assisted in vivo by molecular chaperones such as polyanionic molecules [1,42].”
BackgroundNussbaum-Krammer, C. I., Suhre, M. H., Kremmer, E., Diemer, C., Hess, S., Schätzl, H. M., Scheibel, T., & Vorberg, I. M. (2007) · The FASEB Journal · doi:10.1096/fj.07-8733com · Cited by 17
Honda, R. P. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201800197 · Cited by 18
A simplified recipe for prions
Lee, K. S., & Caughey, B. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703910104 · Cited by 18
Self-citationA systemic analysis of Creutzfeldt Jakob disease cases in Asia
Rasheed, U., Khan, S. I., Khalid, M., Noor, A., & Zafar, S. (2024) · Prion · doi:10.1080/19336896.2024.2311950 · Cited by 23
“It is expressed in various cell types both in the central and peripheral nervous system, but it is largely found in the neurons [3].”
BackgroundDorban, G., Defaweux, V., Heinen, E., & Antoine, N. (2010) · Histochemistry and Cell Biology · doi:10.1007/s00418-010-0687-9 · Cited by 16
Biology and Neuropathology of Prion Diseases
Ironside, J. W., & Head, M. W. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01268-7 · Cited by 19
Brooks, B. D., Albertson, A. E., Jones, J. A., Speare, J. O., & Lewis, R. V. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.07.009 · Cited by 16
Disease‐specific particles without prion protein in prion diseases – phenomenon or epiphenomenon?
Liberski, P. P., & Brown, P. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00867.x · Cited by 17
Qi, X., Moore, R. A., & McGuirl, M. A. (2012) · Biochemistry · doi:10.1021/bi300201e · Cited by 16
Duernberger, Y., Liu, S., Riemschoss, K., Paulsen, L., Bester, R., Kuhn, P., Schölling, M., Lichtenthaler, S. F., & Vorberg, I. M. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00111-18 · Cited by 15
“mechanisms or cofactors required for prion biogenesis in mammals are ill defined (77).”
BackgroundCharacterization of the Prion Protein in Human Urine
Dagdanova, A. V., Ilchenko, S., Notari, S., Yang, Q., Obrenovich, M. E., Hatcher, K., McAnulty, P. A., Huang, L. L., Zou, W., Kong, Q., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.161794 · Cited by 15
Singh, A. K., Mohan, M. L., Isaac, A. O., Luo, X., Petrák, J., Vyoral, D., & Singh, N. (2009) · PLoS ONE · doi:10.1371/annotation/194f4e44-20f0-48eb-bbe9-14e21d18909b · Cited by 15
Endosomal sorting drives the formation of axonal prion protein endoggresomes
Chassefeyre, R., Chaiamarit, T., Verhelle, A., Novak, S. W., de Andrade, L. R., Leitao, A. D. G., Manor, U., & Encalada, S. E. (2021) · Science Advances · doi:10.1126/sciadv.abg3693 · Cited by 14
Schiff, E., Campana, V., Tivodar, S., Lebreton, S., Gousset, K., & Zurzolo, C. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00746.x · Cited by 15
“anomaly in turn could lead to a toxic effect specifically in neurons where PrP exerts its function [reviewed in (54)].”
BackgroundTargeting prion proteins in neurodegenerative disease
Gilch, S., Nussbaum-Krammer, C. I., & Schätzl, H. M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.923 · Cited by 18
“Nevertheless, the function of PrP c remains enigmatic allowing room for various hypotheses [4,24,25] .”
BackgroundBiological polyamines inhibit nucleic-acid-induced polymerisation of prion protein
Bera, A., & Nandi, P. (2007) · Archives of Virology · doi:10.1007/s00705-006-0907-8 · Cited by 13
“Although the exact biological role of prion protein-nucleic acid interaction in vivo is not known at present, it is possible that structural conversion of PrP to the infectious form can be catalysed by cytoplasmic nucleic acids that can play a role in prion diseases [10, 41].”
BackgroundHuman embryonic stem cells rapidly take up and then clear exogenous human and animal prions in vitro
Krejciova, Z., Pells, S., Cancellotti, E., Freile, P., Bishop, M., Samuel, K., Barclay, G. R., Ironside, J. W., Manson, J. C., Turner, M., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2832 · Cited by 13
“In part because of their unique biology [5–7], prions can be difficult to detect, to inactivate and to remove [8–10].”
BackgroundGlycosylation-related gene expression profiling in the brain and spleen of scrapie-affected mouse
Guillerme-Bosselut, F., Forestier, L., Jayat‐Vignoles, C., Vilotte, J.-L., Popa, I., Portoukalian, J., Ledur, A., Laude, H., Julien, R., & Gallet, P. (2009) · Glycobiology · doi:10.1093/glycob/cwp062 · Cited by 13
“Despite the recognized pivotal role of the prion protein (Prusiner 1998), various data indicate that other host factors may be involved in the infection process and contribute to the prion replication (Diaz et al. 2005; Caughey and Baron 2006; Tamguney et al. 2008).”
BackgroundHybrid Lipoic Acid Derivatives to Attack Prion Disease on Multiple Fronts
Bongarzone, S., Tran, H. N. A., Cavalli, A., Roberti, M., Rosini, M., Carloni, P., Legname, G., & Bolognesi, M. L. (2011) · ChemMedChem · doi:10.1002/cmdc.201100072 · Cited by 12
Differential effects of prion particle size on infectivity in vivo and in vitro
Weber, P., Reznicek, L., Mitteregger, G., Kretzschmar, H. A., & Giese, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.115 · Cited by 13
Steunou, S., Chich, J., Rezaei, H., & Vidić, J. (2010) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2010.07.064 · Cited by 12
Exploring Anti-Prion Glyco-Based and Aromatic Scaffolds: A Chemical Strategy for the Quality of Life
Blázquez‐Sánchez, M. T., de Matos, A. M., & Rauter, A. P. (2017) · Molecules · doi:10.3390/molecules22060864 · Cited by 12
“Glycosaminoglycans (GAGs) are biomolecules of interest for prion-related diseases playing important roles in prion formation and infection [22].”
BackgroundRole of lipid in forming an infectious prion?
Wang, F., & Ma, J. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt038 · Cited by 14
Aetiology and pathophysiology of neurodegenerative disorders
Sahoo, R. K., Gupta, T., Smily, Kumar, V., Rani, S., & Gupta, U. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00006-x · Cited by 19
The Prion Protein Preference of Sporadic Creutzfeldt-Jakob Disease Subtypes
Klemm, H. M. J., Welton, J. M., Masters, C. L., Klug, G. M., Boyd, A., Hill, A. F., Collins, S. J., & Lawson, V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.368803 · Cited by 11
“Although misfolding of PrP can occur in the absence of hostderived factors (20), the efficiency of the process is greatly improved when these putative factors are provided in trans in the form of a crude brain homogenate (26, 27).”
BackgroundEnhanced prion protein stability coupled to DNA recognition and milieu acidification
Marques, A. F., Cordeiro, Y., Silva, J. L., & Lima, L. M. T. R. (2009) · Biophysical Chemistry · doi:10.1016/j.bpc.2008.12.011 · Cited by 12
“Currently, there are several candidates to play such a role, such as cellular adhesion molecules, sulfated glycans and nucleic acids (NAs), among others [18].”
BackgroundConformational Isomers of Denatured and Unfolded Proteins: Methods of Production and Applications
Chang, J. (2009) · The Protein Journal · doi:10.1007/s10930-009-9162-7 · Cited by 12
Polymorphism of the Prion Protein in Mammals: A Phylogenetic Approach
Martin, R., Gallet, P., Rocha, D., & Petit, D. P. (2009) · Recent Patents on DNA & Gene Sequences · doi:10.2174/187221509787236156 · Cited by 11
Liberski, P. P., Sikorska, B., Hauw, J., Kopp, N., Streichenberger, N., Giraud, P., Budka, H., Boellaard, J. W., & Brown, P. (2008) · Virus Research · doi:10.1016/j.virusres.2007.11.008 · Cited by 13
Liu, X., & Zhao, Y.-P. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.02.009 · Cited by 11
“TSEs arise in several mammalian species by genetic, infectious, or sporadic means, and include bovine spongiform encephalopathy in cattle, scrapie in sheep, chronic wasting disease in cervids, and Creutzfeldt–Jakob disease and kuru in humans (Prusiner, 1982, 1998; Caughey and Baron, 2006; Collinge, 2001; Aguzzi and Po…”
Prion diseases: a riddle wrapped in a mystery inside an enigma.
Liberski, P. P. (2008) · PubMed · Cited by 12
Is There a Role for Cellular Prion Protein in Intrathymic T Cell Differentiation and Migration?
Terra‐Granado, E., Berbert, L. R., de Meis, J., Nomizo, R., Martins, V. R., Savino, W., & Silva-Barbosa, S. D. (2007) · NeuroImmunoModulation · doi:10.1159/000110649 · Cited by 11
Barenco, M. G., Valori, C. F., Roncoroni, C., Loewer, J., Montrasio, F., & Rossi, D. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21894 · Cited by 10
Bongarzone, S., Staderini, M., & Bolognesi, M. L. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.56 · Cited by 10
Characterization of PrPSc transmission from immune cells to neuronal cells
Tanaka, Y., Sadaike, T., Inoshima, Y., & Ishiguro, N. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.11.007 · Cited by 10
Bento‐Torres, J., Sobral, L. L., dos Reis, R. R., de Oliveira, R. B., Anthony, D. C., Vasconcelos, P. F. D. C., & Diniz, C. W. P. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4504925 · Cited by 11
Benvegnù, S., Franciotta, D. M., Sussman, J., Bachi, A., Zardini, E., Torreri, P., Govaerts, C., Pizzo, S. V., & Legname, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005968 · Cited by 10
“However, while many physiological and putative PrP interacting partners have been described (reviewed in [15]), very little is known about Dpl-interacting proteins.”
Background
Metadata
- Authors
- Caughey, B., & Baron, G. S.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Caughey, Byron
- Baron, Gerald S.
- Venue
- Nature
- Published
- 2006-10
- Volume
- 443
- Issue
- 7113
- Pages
- 803-810
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2057579163
- Cited by
- 295
- References
- 96
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 8 · 2016: 10 · 2015: 11 · 2014: 11 · 2013: 14 · 2012: 19
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- prions, prion disease, prion protein, prion pathogenesis
- MeSH terms
- Animals, Copper, Humans, Ligands, Prions, Prion Diseases, Glycosylphosphatidylinositols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.